The management of acute hypertension in patients with renal dysfunction: Labetalol or nicardipine?

Postgraduate Medicine

Volumn 126, Issue 4, 2014, Pages 124-130

  Varon, Joseph ^a,b   Soto Ruiz, Karina M ^c   Baumann, Brigitte M ^d   Borczuk, Pierre ^e   Cannon, Chad M ^f   Chandra, Abhinav ^g   Cline, David Martin ^h   Diercks, Deborah B ⁱ   Hiestand, Brian ^h   Hsu, Amy ^j   Jois Bilowich, Preeti ^k   Kaminski, Brian ^l   Levy, Phillip ^m   Nowak, Richard M ⁿ   Schrock, Jon W ^o   Peacock, W Frank ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b Dorrington Medical Associates   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^g KAISER PERMANENTE   (United States)

^h WAKE FOREST BAPTIST HEALTH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^l TOLEDO HOSPITAL   (United States)

^m WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ HENRY FORD HOSPITAL   (United States)

^o METROHEALTH MEDICAL CENTER   (United States)

more..

Author keywords

Acute disease; Antihypertensive agents therapeutic use; Hypertension drug therapy; Kidney diseases drug therapy

Indexed keywords

LABETALOL; NICARDIPINE; ANTIHYPERTENSIVE AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SMOKING; TARGET VARIABLE; TREATMENT OUTCOME; ACUTE DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; PROSPECTIVE STUDY;

ACUTE DISEASE; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LABETALOL; MALE; MIDDLE AGED; NICARDIPINE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY;

EID: 84907957229     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2014.07.2790     Document Type: Article

References (21)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-171.
2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199-206.
3. Marik PE, Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth. 2009;21(3):220-229.
4. Pollack C Jr, RCJ. Hypertensive emergencies: acute care evaluation and management. Emergency Medicine Cardiac Research and Education Group. 2008;3:1-9.
5. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68(3):283-297.
6. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Crit Care. 2003;7(5):374-384.
7. Mansoor GA, Frishman WH. Comprehensive management of hypertensive emergencies and urgencies. Heart Dis. 2002;4(6):358-371.
8. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118(1):214-227.
9. Katz JN, Gore JM, Amin A, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J. 2009;158(4):599-606, e591.
10. Deshmukh A, Kumar G, Kumar N, et al. Effect of Joint National Committee VII Report on Hospitalizations for Hypertensive Emergencies in the United States. Am J Cardiol. 2011;108(9):1277-1282.
11. Varon J. The diagnosis and treatment of hypertensive crises. Postgrad Med. 2009;121(1):5-13.
12. Varon J, Peacock W, Garrison N, et al. Prolonged infusion of clevidipine results in safe and predictable blood pressure control in patients with acute severe hypertension. Chest. 2007;132(4):477b.
13. Ram CV. Current concepts in the diagnosis and management of hypertensive urgencies and emergencies. Keio J Med. 1990;39(4): 225-236.
14. Murphy C. Hypertensive emergencies. Emerg Med Clin North Am. 1995;13(4):973-1007.
15. Wilson DJ, Wallin JD, Vlachakis ND, et al. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. Am J Med. 1983;75(4 A):95-102.
16. Wallin JD, Cook ME, Blanski L, et al. Intravenous nicardipine for the treatment of severe hypertension. Am J Med. 1988;85(3):331-338.
17. PDL BioPharma I. Cardene® (nicardipine HCI) prescribing information [online]. http://www.cardeneiv.info/Cardene_Full_PI.pdf. Updated January 2006. Accessed July 16, 2007.
18. Peacock WF, Varon J, Baumann BM, et al. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care. 2011;15(3):R157.
19. Bedford Laboratories. Labetolol HCL Injection USP prescribing information [online]. http://www.bedfordlabs.com/products/inserts/ LBTL-P02.pdf. Updated June 2000. Accessed July 16, 2007.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
21. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49(1):69-75.